16-Mar-17 The USA has long been a top destination for travellers from Gulf Coast Countries seeking healthcare treatments abroad. Since Donald Trump's travel ban was announced, travel bookings from the countries covered have decreased by 80%. With Emiratis alone, travelling abroad for treatment spending USD250,000 per-visit, American specialist facilities are rightly concerned over the implications the ban might have. [image: Arab Health]

15-Mar-17 India's decision to put in place price controls on cardiac stents shows it is a country that isn't business-friendly, say representatives from the US Embassy in New Delhi. The country’s classification of the cardiac stents as an essential medicine requires that they abide by new regulatory guidelines and pricing regulations. [image: Hindustan Times]

11-Mar-17 In India, the prices of all medical devices except for stents, condoms and intrauterine devices can only be raised by up to 10% a year, the National Pharmaceutical Pricing Authority said. The regulator also clarified that all medical devices notified as drugs under the Drugs and Cosmetics Act will have to carry their maximum retail price on their packs. [image: ET Healthworld]

24-Feb-17 China has launched the “two-invoice” system in drug distribution on a trial basis, aiming to improve transparency in drug prices and eliminate excessive profit margins associated with multi-tier distribution models. The two-invoice system had been debated for over a decade. The system is expected to be fully implemented in public hospitals by the end of 2018. [image: Global Compliance News]

22-Feb-17 Romanian healthcare is undergoing considerable reform and development. Both public and private healthcare are expected to improve, expand and develop. Private health networks continue to attract foreign investment. Regina Maria, the second largest player, carried out six investments in 2016. MedLife, the biggest private medical services provider, recorded turnover up 29% and made several acquisitions. [image: Pulse / LinkedIn / Jackie Bojor]